Ligand source activities (1 row/activity)
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
169260419 | 195986 | None | 0 | Human | Functional | pEC50 | = | 9.6 | 9.6 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 377 | 5 | 1 | 5 | 4.4 | C[C@@H](Nc1ncc(-c2cncc(CC(F)(F)F)c2)nn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
CHEMBL5414688 | 195986 | None | 0 | Human | Functional | pEC50 | = | 9.6 | 9.6 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 377 | 5 | 1 | 5 | 4.4 | C[C@@H](Nc1ncc(-c2cncc(CC(F)(F)F)c2)nn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
169260355 | 196629 | None | 3 | Human | Functional | pEC50 | = | 9.6 | 9.6 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 376 | 5 | 1 | 4 | 5.0 | C[C@@H](Nc1cnc(-c2cncc(CC(F)(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
CHEMBL5428306 | 196629 | None | 3 | Human | Functional | pEC50 | = | 9.6 | 9.6 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 376 | 5 | 1 | 4 | 5.0 | C[C@@H](Nc1cnc(-c2cncc(CC(F)(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
169260297 | 196551 | None | 0 | Human | Functional | pEC50 | = | 9.4 | 9.4 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 358 | 6 | 1 | 4 | 4.7 | C[C@@H](Nc1cnc(-c2cncc(CC(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
CHEMBL5426486 | 196551 | None | 0 | Human | Functional | pEC50 | = | 9.4 | 9.4 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 358 | 6 | 1 | 4 | 4.7 | C[C@@H](Nc1cnc(-c2cncc(CC(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
169260304 | 196634 | None | 0 | Human | Functional | pEC50 | = | 8.0 | 8.0 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 307 | 4 | 1 | 3 | 4.8 | Cc1cncc(-c2ccc(N[C@H](C)c3ccc(F)cc3)nc2)c1 | 10.1021/acs.jmedchem.3c00784 | ||
CHEMBL5428424 | 196634 | None | 0 | Human | Functional | pEC50 | = | 8.0 | 8.0 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 307 | 4 | 1 | 3 | 4.8 | Cc1cncc(-c2ccc(N[C@H](C)c3ccc(F)cc3)nc2)c1 | 10.1021/acs.jmedchem.3c00784 | ||
137658912 | 159536 | None | 0 | Human | Functional | pEC50 | = | 7 | 7.0 | - | 1 | Agonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assayAgonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assay |
ChEMBL | 577 | 10 | 3 | 7 | 4.7 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(S(=O)(=O)N(Cc2ccc(CO)o2)c2ccccc2)cc1 | 10.1016/j.bmc.2017.06.016 | ||
CHEMBL4101162 | 159536 | None | 0 | Human | Functional | pEC50 | = | 7 | 7.0 | - | 1 | Agonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assayAgonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assay |
ChEMBL | 577 | 10 | 3 | 7 | 4.7 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(S(=O)(=O)N(Cc2ccc(CO)o2)c2ccccc2)cc1 | 10.1016/j.bmc.2017.06.016 | ||
137660243 | 159378 | None | 0 | Human | Functional | pEC50 | = | 6 | 6.0 | - | 1 | Agonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assayAgonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assay |
ChEMBL | 476 | 5 | 2 | 5 | 4.2 | CN(c1ccccc1)S(=O)(=O)c1ccc(NC(=S)NC(=O)c2ccc3cccnc3c2)cc1 | 10.1016/j.bmc.2017.06.016 | ||
CHEMBL4099471 | 159378 | None | 0 | Human | Functional | pEC50 | = | 6 | 6.0 | - | 1 | Agonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assayAgonist activity at beta-galactosidase enzyme fragment-fused GPR55 (unknown origin) expressed in CHOK1 cells assessed as increase in N-terminal deletion beta-galactosidase mutant-tagged beta arrestin recruitment measured for 1 sec by chemiluminescence based pathhunter assay |
ChEMBL | 476 | 5 | 2 | 5 | 4.2 | CN(c1ccccc1)S(=O)(=O)c1ccc(NC(=S)NC(=O)c2ccc3cccnc3c2)cc1 | 10.1016/j.bmc.2017.06.016 | ||
1724914 | 47404 | None | 14 | Human | Functional | pEC50 | = | 6 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 474 | 3 | 0 | 5 | 7.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 | nan | ||
CHEMBL1544821 | 47404 | None | 14 | Human | Functional | pEC50 | = | 6 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 474 | 3 | 0 | 5 | 7.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 | nan | ||
1172037 | 53300 | None | 0 | Human | Functional | pEC50 | = | 6.0 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 461 | 6 | 1 | 8 | 5.1 | COc1ccc2cc(C)c3nnc(SCC(=O)Nc4nc(-c5ccccc5)cs4)n3c2c1 | nan | ||
CHEMBL1599391 | 53300 | None | 0 | Human | Functional | pEC50 | = | 6.0 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 461 | 6 | 1 | 8 | 5.1 | COc1ccc2cc(C)c3nnc(SCC(=O)Nc4nc(-c5ccccc5)cs4)n3c2c1 | nan | ||
16320697 | 47493 | None | 2 | Human | Functional | pEC50 | = | 6.0 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 472 | 7 | 1 | 7 | 5.4 | COc1ccc(C2=NN(c3nc(-c4ccc(CNC(C)=O)cc4)cs3)C(c3ccco3)C2)cc1 | nan | ||
CHEMBL1545460 | 47493 | None | 2 | Human | Functional | pEC50 | = | 6.0 | 6.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 472 | 7 | 1 | 7 | 5.4 | COc1ccc(C2=NN(c3nc(-c4ccc(CNC(C)=O)cc4)cs3)C(c3ccco3)C2)cc1 | nan | ||
5336094 | 45419 | None | 5 | Human | Functional | pEC50 | = | 6.0 | 6.0 | 2 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 419 | 8 | 1 | 6 | 5.5 | CCOC(=O)/C(=C\c1ccccc1)C(=O)c1cc(C(C)=O)c(Nc2ccccc2)s1 | nan | ||
CHEMBL1527447 | 45419 | None | 5 | Human | Functional | pEC50 | = | 6.0 | 6.0 | 2 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 419 | 8 | 1 | 6 | 5.5 | CCOC(=O)/C(=C\c1ccccc1)C(=O)c1cc(C(C)=O)c(Nc2ccccc2)s1 | nan | ||
4562786 | 49072 | None | 6 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 329 | 4 | 2 | 8 | 1.5 | CN1CCN(c2nc(Nc3ccccc3)nc(N)c2[N+](=O)[O-])CC1 | nan | ||
CHEMBL1561279 | 49072 | None | 6 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 329 | 4 | 2 | 8 | 1.5 | CN1CCN(c2nc(Nc3ccccc3)nc(N)c2[N+](=O)[O-])CC1 | nan | ||
16060986 | 24116 | None | 0 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 440 | 10 | 0 | 4 | 5.0 | COc1ccc(SC[C@H](CC(C)C)N2CCN(CCc3ccccc3)CCC2=O)cc1 | nan | ||
CHEMBL1338630 | 24116 | None | 0 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 440 | 10 | 0 | 4 | 5.0 | COc1ccc(SC[C@H](CC(C)C)N2CCN(CCc3ccccc3)CCC2=O)cc1 | nan | ||
3662261 | 33335 | None | 5 | Human | Functional | pEC50 | = | 5.0 | 5.0 | 1 | 3 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 401 | 6 | 2 | 6 | 3.2 | CC/C(Nc1ccc(OC)cc1OC)=C1/C(=O)NC(=O)N(C2CCCCC2)C1=O | nan | ||
CHEMBL1418843 | 33335 | None | 5 | Human | Functional | pEC50 | = | 5.0 | 5.0 | 1 | 3 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 401 | 6 | 2 | 6 | 3.2 | CC/C(Nc1ccc(OC)cc1OC)=C1/C(=O)NC(=O)N(C2CCCCC2)C1=O | nan | ||
169260346 | 195381 | None | 0 | Human | Functional | pEC50 | = | 7.0 | 7.0 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 361 | 4 | 1 | 3 | 5.5 | C[C@@H](Nc1ccc(-c2cncc(C(F)(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
CHEMBL5402444 | 195381 | None | 0 | Human | Functional | pEC50 | = | 7.0 | 7.0 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 361 | 4 | 1 | 3 | 5.5 | C[C@@H](Nc1ccc(-c2cncc(C(F)(F)F)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 | ||
24817051 | 52058 | None | 5 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 392 | 7 | 0 | 4 | 4.9 | CCCc1ccc2oc(C(=O)N(Cc3ccncc3)CC3CCCO3)c(C)c2c1 | nan | ||
CHEMBL1587026 | 52058 | None | 5 | Human | Functional | pEC50 | = | 5.0 | 5.0 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 392 | 7 | 0 | 4 | 4.9 | CCCc1ccc2oc(C(=O)N(Cc3ccncc3)CC3CCCO3)c(C)c2c1 | nan | ||
1792197 | 931 | None | 16 | Human | Functional | pEC50 | = | 6.9 | 6.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | nan | ||
5563 | 931 | None | 16 | Human | Functional | pEC50 | = | 6.9 | 6.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | nan | ||
CHEMBL1532240 | 931 | None | 16 | Human | Functional | pEC50 | = | 6.9 | 6.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | nan | ||
2964873 | 33177 | None | 6 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 377 | 5 | 1 | 4 | 5.6 | COc1cc2c(cc1NC(=O)CSc1ccc(C)cc1)oc1ccccc12 | nan | ||
CHEMBL1417504 | 33177 | None | 6 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 377 | 5 | 1 | 4 | 5.6 | COc1cc2c(cc1NC(=O)CSc1ccc(C)cc1)oc1ccccc12 | nan | ||
16253428 | 59187 | None | 4 | Human | Functional | pEC50 | = | 4.9 | 4.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 445 | 5 | 1 | 7 | 5.4 | Cc1ccc(-c2csc(NC(=O)CSc3nnc4cc(C)c5ccccc5n34)n2)cc1 | nan | ||
CHEMBL1699880 | 59187 | None | 4 | Human | Functional | pEC50 | = | 4.9 | 4.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 445 | 5 | 1 | 7 | 5.4 | Cc1ccc(-c2csc(NC(=O)CSc3nnc4cc(C)c5ccccc5n34)n2)cc1 | nan | ||
1724914 | 47404 | None | 14 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 474 | 3 | 0 | 5 | 7.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 | nan | ||
CHEMBL1544821 | 47404 | None | 14 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965]PUBCHEM_BIOASSAY: SAR analysis of selective Agonists of GPR55 using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1961, AID1965] |
ChEMBL | 474 | 3 | 0 | 5 | 7.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccc(C(F)(F)F)cc21 | nan | ||
127037894 | 137200 | None | 0 | Human | Functional | pEC50 | = | 7.9 | 7.9 | - | 1 | Agonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling by fura 2-based digital epifluorescence microscopyAgonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling by fura 2-based digital epifluorescence microscopy |
ChEMBL | 515 | 7 | 3 | 4 | 5.3 | Cc1ccc(CNS(=O)(=O)c2ccc(NC(=S)NC(=O)c3ccc(-c4ccccc4)cc3)cc2)cc1 | 10.1016/j.ejmech.2015.10.050 | ||
CHEMBL3747626 | 137200 | None | 0 | Human | Functional | pEC50 | = | 7.9 | 7.9 | - | 1 | Agonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling by fura 2-based digital epifluorescence microscopyAgonist activity at human GPR55 expressed in HEK293 cells assessed as calcium signalling by fura 2-based digital epifluorescence microscopy |
ChEMBL | 515 | 7 | 3 | 4 | 5.3 | Cc1ccc(CNS(=O)(=O)c2ccc(NC(=S)NC(=O)c3ccc(-c4ccccc4)cc3)cc2)cc1 | 10.1016/j.ejmech.2015.10.050 | ||
6412316 | 42264 | None | 12 | Human | Functional | pEC50 | = | 4.9 | 4.9 | 2 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 403 | 5 | 0 | 6 | 5.1 | CCOC(=O)c1nnc(-c2ccc(C)cc2)nc1Oc1ccc(Cl)cc1Cl | nan | ||
CHEMBL1497403 | 42264 | None | 12 | Human | Functional | pEC50 | = | 4.9 | 4.9 | 2 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 403 | 5 | 0 | 6 | 5.1 | CCOC(=O)c1nnc(-c2ccc(C)cc2)nc1Oc1ccc(Cl)cc1Cl | nan | ||
1959655 | 34666 | None | 18 | Human | Functional | pEC50 | = | 4.9 | 4.9 | -1 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 406 | 3 | 0 | 5 | 6.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccccc21 | nan | ||
CHEMBL1430016 | 34666 | None | 18 | Human | Functional | pEC50 | = | 4.9 | 4.9 | -1 | 2 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 406 | 3 | 0 | 5 | 6.2 | O=C(CSc1nc2ccccc2s1)N1c2ccccc2Sc2ccccc21 | nan | ||
3230764 | 53915 | None | 2 | Human | Functional | pEC50 | = | 4.9 | 4.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 375 | 4 | 0 | 7 | 1.3 | O=CN1CCN(c2ncnc3c2nnn3Cc2c(F)cccc2Cl)CC1 | nan | ||
CHEMBL1605039 | 53915 | None | 2 | Human | Functional | pEC50 | = | 4.9 | 4.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 375 | 4 | 0 | 7 | 1.3 | O=CN1CCN(c2ncnc3c2nnn3Cc2c(F)cccc2Cl)CC1 | nan | ||
1130106 | 46843 | None | 11 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 403 | 3 | 0 | 5 | 5.5 | Cn1c(SCC(=O)N2c3ccccc3Sc3ccccc32)nc2ccccc21 | nan | ||
CHEMBL1540265 | 46843 | None | 11 | Human | Functional | pEC50 | = | 5.9 | 5.9 | - | 1 | PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279]PUBCHEM_BIOASSAY: Image-based HTS for Selective Agonists of GPR55. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1965, AID2338, AID2339, AID2340, AID2341, AID2347, AID2843, AID2844, AID434922, AID434924, AID434925, AID434928, AID434929, AID463192, AID485279] |
ChEMBL | 403 | 3 | 0 | 5 | 5.5 | Cn1c(SCC(=O)N2c3ccccc3Sc3ccccc32)nc2ccccc21 | nan | ||
169260368 | 196455 | None | 0 | Human | Functional | pEC50 | = | 7.9 | 7.9 | - | 1 | Agonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysisAgonist activity at human GPR55 expressed in human HEK293 cells assessed as effect on calcium flux incubated for 5 mins by FLIPR analysis |
ChEMBL | 333 | 5 | 1 | 3 | 5.3 | C[C@@H](Nc1ccc(-c2cncc(C3CC3)c2)cn1)c1ccc(F)cc1 | 10.1021/acs.jmedchem.3c00784 |
Showing 1 to 50 of 1,467 entries
Ligands (move mouse cursor over ligand name to see structure) | Receptor | Activity | Chemical information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
|
Ligands (move mouse cursor over ligand name to see structure)
| Receptor
| Activity
| Chemical information
| |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sel. page | Common name
| GPCRdb ID
| Reference ligand
| Vendors | Species
| Assay Type
| Activity Type
| Activity Relation
| Activity Value | p-value (-log) | Fold selectivity | Tested GPCRs | Assay Description
| Source
| Mol weight | Rot Bonds | H don | H acc | LogP | Smiles
| DOI
| |
127030161 | 138925 | None | 0 | Human | Binding | pEC50 | = | 9.4 | 9.4 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 440 | 5 | 0 | 7 | 2.5 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)C4CCCO4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3781437 | 138925 | None | 0 | Human | Binding | pEC50 | = | 9.4 | 9.4 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 440 | 5 | 0 | 7 | 2.5 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)C4CCCO4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127034073 | 138962 | None | 0 | Human | Binding | pEC50 | = | 9.3 | 9.3 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 452 | 5 | 0 | 7 | 3.7 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4cccs4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3781953 | 138962 | None | 0 | Human | Binding | pEC50 | = | 9.3 | 9.3 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 452 | 5 | 0 | 7 | 3.7 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4cccs4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127034071 | 138809 | None | 0 | Human | Binding | pEC50 | = | 9.2 | 9.2 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 446 | 5 | 0 | 6 | 3.6 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3779969 | 138809 | None | 0 | Human | Binding | pEC50 | = | 9.2 | 9.2 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 446 | 5 | 0 | 6 | 3.6 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127029838 | 138932 | None | 0 | Human | Binding | pEC50 | = | 9.2 | 9.2 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 426 | 4 | 0 | 6 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)C(C)(C)C)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3781521 | 138932 | None | 0 | Human | Binding | pEC50 | = | 9.2 | 9.2 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 426 | 4 | 0 | 6 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)C(C)(C)C)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127034069 | 138902 | None | 0 | Human | Binding | pEC50 | = | 9.1 | 9.1 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 436 | 5 | 0 | 7 | 3.2 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccco4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3781158 | 138902 | None | 0 | Human | Binding | pEC50 | = | 9.1 | 9.1 | - | 1 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 436 | 5 | 0 | 7 | 3.2 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccco4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127030160 | 138808 | None | 0 | Human | Binding | pEC50 | = | 8.9 | 8.9 | - | 0 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 476 | 7 | 0 | 7 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)COc4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3779954 | 138808 | None | 0 | Human | Binding | pEC50 | = | 8.9 | 8.9 | - | 0 | Partial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assayPartial agonist activity at recombinant human GPR55 expressed in HEK293 cells after 5 mins by xCELLigence assay |
ChEMBL | 476 | 7 | 0 | 7 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)COc4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
90667664 | 109576 | None | 0 | Human | Binding | pEC50 | = | 6 | 6.0 | - | 0 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 620 | 21 | 7 | 11 | 2.4 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO)COP(=O)(O)O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O | 10.1039/C3MD00394A | ||
CHEMBL3221204 | 109576 | None | 0 | Human | Binding | pEC50 | = | 6 | 6.0 | - | 0 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 620 | 21 | 7 | 11 | 2.4 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO)COP(=O)(O)O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O | 10.1039/C3MD00394A | ||
73353471 | 90655 | None | 0 | Human | Binding | pEC50 | = | 6 | 6.0 | - | 0 | Agonist activity at human GPR55 transfected in CHO cells after 90 mins by beta-arrestin translocation assay relative to LPIAgonist activity at human GPR55 transfected in CHO cells after 90 mins by beta-arrestin translocation assay relative to LPI |
ChEMBL | 620 | 21 | 7 | 11 | 2.4 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO)COP(=O)(O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O | 10.1021/jm4005175 | ||
CHEMBL2387746 | 90655 | None | 0 | Human | Binding | pEC50 | = | 6 | 6.0 | - | 0 | Agonist activity at human GPR55 transfected in CHO cells after 90 mins by beta-arrestin translocation assay relative to LPIAgonist activity at human GPR55 transfected in CHO cells after 90 mins by beta-arrestin translocation assay relative to LPI |
ChEMBL | 620 | 21 | 7 | 11 | 2.4 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](CO)COP(=O)(O)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O | 10.1021/jm4005175 | ||
11338511 | 109570 | None | 0 | Human | Binding | pEC50 | = | 5.0 | 5.0 | - | 2 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 398 | 4 | 0 | 4 | 5.0 | O=C1/C(=C/c2cccc(OCc3ccc(Cl)cc3)c2)N=C2SCCCCN12 | 10.1039/C3MD00394A | ||
CHEMBL3221198 | 109570 | None | 0 | Human | Binding | pEC50 | = | 5.0 | 5.0 | - | 2 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 398 | 4 | 0 | 4 | 5.0 | O=C1/C(=C/c2cccc(OCc3ccc(Cl)cc3)c2)N=C2SCCCCN12 | 10.1039/C3MD00394A | ||
1792197 | 931 | None | 16 | Human | Binding | pEC50 | = | 7.0 | 7.0 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | 10.1016/j.bmc.2017.06.016 | ||
5563 | 931 | None | 16 | Human | Binding | pEC50 | = | 7.0 | 7.0 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | 10.1016/j.bmc.2017.06.016 | ||
CHEMBL1532240 | 931 | None | 16 | Human | Binding | pEC50 | = | 7.0 | 7.0 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 481 | 7 | 2 | 5 | 4.0 | COc1ccccc1/C=C/C(=O)NC(=S)Nc1ccc(cc1)S(=O)(=O)N(c1ccccc1)C | 10.1016/j.bmc.2017.06.016 | ||
56649300 | 157863 | None | 30 | Rat | Binding | pEC50 | = | 6.9 | 6.9 | - | 0 | CHO-based cAMP assay (rat)CHO-based cAMP assay (rat) |
ChEMBL | 392 | 4 | 1 | 4 | 3.7 | Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O | 10.6019/CHEMBL4507305 | ||
CHEMBL4082756 | 157863 | None | 30 | Rat | Binding | pEC50 | = | 6.9 | 6.9 | - | 0 | CHO-based cAMP assay (rat)CHO-based cAMP assay (rat) |
ChEMBL | 392 | 4 | 1 | 4 | 3.7 | Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O | 10.6019/CHEMBL4507305 | ||
16078 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
16078.0 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
2424 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
4109 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
CHEMBL465 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
DB00470 | 1362 | None | 15 | Human | Binding | pEC50 | = | 4.9 | 4.9 | - | 6 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 314 | 4 | 1 | 2 | 5.7 | CCCCCc1cc(O)c2c(c1)OC([C@H]1[C@H]2C=C(C)CC1)(C)C | 10.1039/C3MD00394A | ||
127034071 | 138809 | None | 0 | Human | Binding | pEC50 | = | 7.8 | 7.8 | - | 1 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 446 | 5 | 0 | 6 | 3.6 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3779969 | 138809 | None | 0 | Human | Binding | pEC50 | = | 7.8 | 7.8 | - | 1 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 446 | 5 | 0 | 6 | 3.6 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
56649300 | 157863 | None | 30 | Rat | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | cAMP increase in rat primary cultured striatal neuronscAMP increase in rat primary cultured striatal neurons |
ChEMBL | 392 | 4 | 1 | 4 | 3.7 | Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O | 10.6019/CHEMBL4507305 | ||
CHEMBL4082756 | 157863 | None | 30 | Rat | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | cAMP increase in rat primary cultured striatal neuronscAMP increase in rat primary cultured striatal neurons |
ChEMBL | 392 | 4 | 1 | 4 | 3.7 | Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O | 10.6019/CHEMBL4507305 | ||
5561 | 1884 | None | 13 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assayAgonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assay |
ChEMBL | 471 | 4 | 1 | 5 | 3.6 | Fc1ccc(cc1)c1ccc(cc1C(=O)N1CCN(CC1)c1ccc(cc1F)N)S(=O)(=O)C | 10.1016/j.ejmech.2015.10.050 | ||
59822766 | 1884 | None | 13 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assayAgonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assay |
ChEMBL | 471 | 4 | 1 | 5 | 3.6 | Fc1ccc(cc1)c1ccc(cc1C(=O)N1CCN(CC1)c1ccc(cc1F)N)S(=O)(=O)C | 10.1016/j.ejmech.2015.10.050 | ||
CHEMBL3747673 | 1884 | None | 13 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assayAgonist activity at human GPR55 expressed in Saccharomyces cerevisiae by beta-galactosidase reporter assay |
ChEMBL | 471 | 4 | 1 | 5 | 3.6 | Fc1ccc(cc1)c1ccc(cc1C(=O)N1CCN(CC1)c1ccc(cc1F)N)S(=O)(=O)C | 10.1016/j.ejmech.2015.10.050 | ||
1172084 | 929 | None | 10 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 479 | 6 | 1 | 8 | 5.2 | COc1ccc2c(c1)n1c(SCC(=O)Nc3scc(n3)c3ccc(cc3)F)nnc1c(c2)C | 10.1016/j.bmc.2017.06.016 | ||
5564 | 929 | None | 10 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 479 | 6 | 1 | 8 | 5.2 | COc1ccc2c(c1)n1c(SCC(=O)Nc3scc(n3)c3ccc(cc3)F)nnc1c(c2)C | 10.1016/j.bmc.2017.06.016 | ||
CHEMBL1718432 | 929 | None | 10 | Human | Binding | pEC50 | = | 6.8 | 6.8 | - | 0 | Agonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assayAgonist activity at HA-epitope-tagged variant of GPR55E with serine enhanced C terminus (unknown origin) expressed in human U2OS cells assessed as increase in GFP-tagged beta arrestin2 recruitment after 75 mins by fluorescence assay |
ChEMBL | 479 | 6 | 1 | 8 | 5.2 | COc1ccc2c(c1)n1c(SCC(=O)Nc3scc(n3)c3ccc(cc3)F)nnc1c(c2)C | 10.1016/j.bmc.2017.06.016 | ||
142635551 | 174134 | None | 0 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 0 | Inverse agonist activity at GPR55 in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assayInverse agonist activity at GPR55 in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay |
ChEMBL | 307 | 1 | 2 | 5 | 2.4 | O=C1C(Cl)=C(N2CCCCC2)C(=O)c2c(O)ccc(O)c21 | 10.1021/acsmedchemlett.8b00333 | ||
CHEMBL4543362 | 174134 | None | 0 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 0 | Inverse agonist activity at GPR55 in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assayInverse agonist activity at GPR55 in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay |
ChEMBL | 307 | 1 | 2 | 5 | 2.4 | O=C1C(Cl)=C(N2CCCCC2)C(=O)c2c(O)ccc(O)c21 | 10.1021/acsmedchemlett.8b00333 | ||
104895 | 1184 | None | 15 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 4 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 376 | 10 | 3 | 3 | 5.7 | CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C | 10.1039/C3MD00394A | ||
730 | 1184 | None | 15 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 4 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 376 | 10 | 3 | 3 | 5.7 | CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C | 10.1039/C3MD00394A | ||
734 | 1184 | None | 15 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 4 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 376 | 10 | 3 | 3 | 5.7 | CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C | 10.1039/C3MD00394A | ||
CHEMBL559612 | 1184 | None | 15 | Human | Binding | pEC50 | = | 5.8 | 5.8 | - | 4 | Agonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation methodAgonist activity at human GPR55 expressed in CHO cells assessed as induction of LPI-induced beta-arrestin recruitment by beta-galactosidase enzyme fragment complementation method |
ChEMBL | 376 | 10 | 3 | 3 | 5.7 | CCCCCCC(c1ccc(c(c1)O)[C@@H]1C[C@H](O)CC[C@H]1CCCO)(C)C | 10.1039/C3MD00394A | ||
127030160 | 138808 | None | 0 | Human | Binding | pEC50 | = | 7.7 | 7.7 | - | 0 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 476 | 7 | 0 | 7 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)COc4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3779954 | 138808 | None | 0 | Human | Binding | pEC50 | = | 7.7 | 7.7 | - | 0 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 476 | 7 | 0 | 7 | 3.4 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)COc4ccccc4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127034068 | 138946 | None | 0 | Human | Binding | pEC50 | = | 7.7 | 7.7 | - | 0 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 436 | 5 | 0 | 7 | 3.2 | COc1ccc2c(c1)OC(C)(C)c1cnn(CCN3CCN(C(=O)c4ccco4)CC3)c1-2 | 10.1021/acs.jmedchem.5b01331 | ||
CHEMBL3781764 | 138946 | None | 0 | Human | Binding | pEC50 | = | 7.7 | 7.7 | - | 0 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 436 | 5 | 0 | 7 | 3.2 | COc1ccc2c(c1)OC(C)(C)c1cnn(CCN3CCN(C(=O)c4ccco4)CC3)c1-2 | 10.1021/acs.jmedchem.5b01331 | ||
127034069 | 138902 | None | 0 | Human | Binding | pEC50 | = | 7.7 | 7.7 | - | 1 | Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM)Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM) |
ChEMBL | 436 | 5 | 0 | 7 | 3.2 | COc1ccc2c(c1)OC(C)(C)c1cn(CCN3CCN(C(=O)c4ccco4)CC3)nc1-2 | 10.1021/acs.jmedchem.5b01331 |
Showing 1 to 50 of 248 entries